POST Online Media Lite Edition



 

New England Peptide appoints CEO and CFO

Christian Fernsby |
Gardner, Mass., USA - New England Peptide, a provider of peptides for pharmaceutical research and development, announced the appointment of Martina Diekmann to the role of CEO and David Gavlik to the role of CFO.


Martina Diekmann has previously held several global management positions with leading, world-class CDMOs, including the Bachem Group and Solvias AG.

Ms. Diekmann holds a Ph.D. in Pharmaceutical Chemistry from the University of Bonn, Germany.

David Gavlik has 25 years of experience in all aspects of financial management and a track record of successful integration and consolidation of add on acquisitions, which he gained as Vice President of Finance from Comark and Lista International.

LATEST 5 MOVES FROM Massachusetts